Dresden Pharmaceuticals has decided to go ahead and start clinical trials on a potential new drug. The total R&D costs are estimated to reach around $875,000,000 with clinical trials mounting to $145,000,000. The current market size is estimated to be around 3,000,000 and is expected to grow at 4 percent every year. The market share Dresden hopes to capture in the first year is 7 percent, and is projected to grow by 25 percent each year for the next 4 years. A monthly prescription is anticipated to generate revenue of $420 while incurring variable costs of $150. A discount rate of 8 percent is assumed Dresden Pharmaceuticals Data Market Size Unit (monthly Rx) revenue (5) Unit (monthly Rox) cost (5) Discount ate percent 3,000,000 420 150 Project Costs RSD IS) Clinical Trials (5) 875,000,000 165,000,000 Calculate the annual cost incurred for the second year. $1,224, 120,000 $638,820,000 S884.520,000 5491.400,000